| A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates (NCT04544787) | Pierre Van Damme | 2018-10-22 |
| GB001 in Adult Subjects With Moderate to Severe Asthma (NCT03683576) | GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. | 2018-10-22 |
| Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice (NCT03961022) | Natural Origins | 2018-10-22 |
| CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC (NCT03725254) | Fudan University | 2018-10-20 |
| PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma (NCT03701022) | Peking University | 2018-10-20 |
| Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia (NCT03709719) | Assistance Publique - Hôpitaux de Paris | 2018-10-20 |
| A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients (NCT03468322) | TWi Biotechnology, Inc. | 2018-10-20 |
| The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection (NCT03711487) | West China Hospital | 2018-10-20 |
| Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy (NCT03710356) | Assistance Publique - Hôpitaux de Paris | 2018-10-20 |
| Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System (NCT04317573) | National University Health System, Singapore | 2018-10-19 |
| A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis (NCT03688555) | Idorsia Pharmaceuticals Ltd. | 2018-10-19 |
| Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (NCT03709953) | Guangzhou Institute of Respiratory Disease | 2018-10-19 |
| LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI) (NCT03377426) | Novartis Pharmaceuticals | 2018-10-19 |
| A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799) (NCT03631784) | Merck Sharp & Dohme LLC | 2018-10-19 |
| Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam (NCT04072328) | DongGuk University | 2018-10-19 |
| Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma (NCT03668730) | Sun Yat-sen University | 2018-10-19 |
| A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma (NCT03693807) | Memorial Sloan Kettering Cancer Center | 2018-10-18 |
| A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis (NCT03678688) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-10-18 |
| A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (NCT03567616) | AbbVie | 2018-10-18 |
| Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer (NCT03637543) | Beth Israel Deaconess Medical Center | 2018-10-18 |
| Sodium Oxybate in Idiopathic Hypersomnia (NCT03597555) | University Hospital, Montpellier | 2018-10-18 |
| FUSCC Refractory TNBC Umbrella (FUTURE) (NCT03805399) | Fudan University | 2018-10-18 |
| CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer (NCT04077671) | Chiesi Farmaceutici S.p.A. | 2018-10-17 |
| A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL) (NCT03743246) | Celgene | 2018-10-17 |
| Diet, Diabetes and Periodontitis (NCT03407508) | Kristianstad University | 2018-10-17 |
| Diadem to Investigate the Activity and Safety of Durvalumab (NCT04115111) | Mario Negri Institute for Pharmacological Research | 2018-10-17 |
| Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC (NCT03646461) | University of California, San Diego | 2018-10-17 |
| Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®) (NCT03643107) | Allarity Therapeutics | 2018-10-17 |
| Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease (NCT03720418) | Sio Gene Therapies | 2018-10-17 |
| Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) (NCT03598608) | Merck Sharp & Dohme LLC | 2018-10-17 |
| Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer (NCT03651271) | Parker Institute for Cancer Immunotherapy | 2018-10-17 |
| Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma (NCT03590652) | University of California, San Diego | 2018-10-17 |
| Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome (NCT03732534) | Neurocrine Biosciences | 2018-10-17 |
| Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa (NCT03638830) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-17 |
| Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] (NCT03428607) | Samsung Medical Center | 2018-10-17 |
| Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT03614728) | GlaxoSmithKline | 2018-10-16 |
| BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer (NCT03695250) | Edward Kim | 2018-10-16 |
| Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer (NCT03982485) | RenJi Hospital | 2018-10-16 |
| An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers (NCT03662659) | Bristol-Myers Squibb | 2018-10-16 |
| Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin (NCT04446572) | Universidad Complutense de Madrid | 2018-10-16 |
| Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies (NCT03654612) | China International Medical Foundation | 2018-10-16 |
| Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation (NCT03398434) | Novartis Pharmaceuticals | 2018-10-16 |
| Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. (NCT03724071) | Transgene | 2018-10-16 |
| ET-01 in Subjects With Lateral Canthal Lines, LCL-208 (NCT03839693) | Eirion Therapeutics Inc. | 2018-10-16 |
| Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC (NCT03703596) | Sichuan Cancer Hospital and Research Institute | 2018-10-16 |
| Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma (NCT03610490) | M.D. Anderson Cancer Center | 2018-10-16 |
| Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT03708822) | Sun Yat-sen University | 2018-10-15 |
| Betaine Effect in Speed-strength Athletes (NCT03702205) | Poznan University of Life Sciences | 2018-10-15 |
| Traditional Chinese Medicine in Management of Childhood Asthma (NCT03645889) | KK Women's and Children's Hospital | 2018-10-15 |
| A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) (NCT03448692) | Pfizer | 2018-10-15 |
| Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder (NCT03625453) | Abide Therapeutics | 2018-10-15 |
| Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients (NCT03456999) | Novartis Pharmaceuticals | 2018-10-15 |
| Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226) (NCT03639181) | Genor Biopharma Co., Ltd. | 2018-10-15 |
| Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H) (NCT06400238) | National Cancer Institute (NCI) | 2018-10-15 |
| A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model (NCT03691623) | Enanta Pharmaceuticals, Inc | 2018-10-15 |
| A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (NCT03558503) | UroGen Pharma Ltd. | 2018-10-15 |
| Behavioral Economic Analysis of Demand for Marijuana (NCT03518567) | Brown University | 2018-10-15 |
| Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia (NCT03697707) | Mendus | 2018-10-15 |
| Photobiomodulation With Red and Infrared LED Device for Temporomandibular Dysfunction (NCT03696706) | University of Nove de Julho | 2018-10-15 |
| Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer (NCT03624309) | Hunan Cancer Hospital | 2018-10-15 |
| Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee (NCT03691974) | Regeneron Pharmaceuticals | 2018-10-15 |
| Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA (NCT03712345) | InflaRx GmbH | 2018-10-15 |
| Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer (NCT03709082) | University of Kansas Medical Center | 2018-10-15 |
| Tinostamustine Conditioning and Autologous Stem Cell (NCT03687125) | Mundipharma-EDO GmbH | 2018-10-15 |
| A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa (NCT03607487) | Incyte Corporation | 2018-10-15 |
| Intensive Nutrition in Critically Ill Adults (NCT03292237) | Australian and New Zealand Intensive Care Research Centre | 2018-10-15 |
| Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA) (NCT03354962) | Institut Claudius Regaud | 2018-10-15 |
| NNITS-Nitazoxanide for Norovirus in Transplant Patients Study (NCT03395405) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-10-15 |
| Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan (NCT04133987) | National Taiwan University Hospital | 2018-10-15 |
| Trifocal Diffractive Intraocular Lens After Cataract Extraction With Phacoemulsification (NCT04465279) | Alexandria University | 2018-10-15 |
| Dabrafenib + Trametinib + PDR001 In Colorectal Cancer (NCT03668431) | Massachusetts General Hospital | 2018-10-15 |
| A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis (NCT03544229) | Millennium Pharmaceuticals, Inc. | 2018-10-14 |
| Allogenic Cord Blood Transfusion in Patients With Autism (NCT03786744) | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 2018-10-12 |
| Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI (NCT04149990) | Jacob Moller | 2018-10-12 |
| Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering (NCT02441673) | Lagos State Health Service Commission | 2018-10-12 |
| Child Discomfort and Parental Acceptability of Silver Diamine Fluoride and Alternative Restorative Treatment (NCT04654624) | Nourhan M.Aly | 2018-10-12 |
| Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03587311) | National Cancer Institute (NCI) | 2018-10-12 |
| A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia (NCT03533244) | Allgenesis Biotherapeutics Inc. | 2018-10-11 |
| Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation (NCT03630640) | Assistance Publique - Hôpitaux de Paris | 2018-10-11 |
| A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib (NCT03744715) | Spectrum Pharmaceuticals, Inc | 2018-10-11 |
| Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC (NCT03567720) | OncoSec Medical Incorporated | 2018-10-11 |
| Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy (NCT03640481) | Kadmon, a Sanofi Company | 2018-10-11 |
| A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome (NCT03721107) | 4D pharma plc | 2018-10-11 |
| Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery (NCT04450095) | Bnai Zion Medical Center | 2018-10-11 |
| Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer (NCT03759431) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-10-11 |
| Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy (NCT03603795) | French Innovative Leukemia Organisation | 2018-10-11 |
| Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia (NCT03575325) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-11 |
| Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM (NCT03008148) | Johnpro Biotech, Inc. | 2018-10-11 |
| Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) (NCT03689699) | Mark Stein | 2018-10-11 |
| BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma (NCT03264131) | UNC Lineberger Comprehensive Cancer Center | 2018-10-11 |
| Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis (NCT03966742) | Rabin Medical Center | 2018-10-11 |
| Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) (NCT03615040) | University of Leicester | 2018-10-11 |
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial (NCT03699904) | Belfast Health and Social Care Trust | 2018-10-11 |
| Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A (NCT03700229) | Peking Union Medical College Hospital | 2018-10-10 |
| Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure (NCT03552016) | University of Missouri-Columbia | 2018-10-10 |
| Tacrolimus for Malar Edema (NCT03715387) | University of British Columbia | 2018-10-10 |
| A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. (NCT03507790) | Cognition Therapeutics | 2018-10-10 |
| A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma (NCT03676985) | Lee's Pharmaceutical Limited | 2018-10-10 |
| TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study (NCT03364270) | Balaji Tamarappoo | 2018-10-10 |
| EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC (NCT03648697) | Fujian Cancer Hospital | 2018-10-10 |